Pharmacologic Treatment of Attention Deficit–Hyperactivity Disorder

Since report in 1937 of positive effects of an amphetamine compound on ADHD symptoms and approval of methylphenidate by FDA in 1955, many studies of pharmacotherapy have been published. This review summarises recent evidence on medications for ADHD approved by regulatory agencies


New England Journal of Medicine